Bristol-Myers Squibb Co (BMY)
48.30
+0.46
(+0.96%)
USD |
NYSE |
Apr 18, 16:00
48.30
0.00 (0.00%)
After-Hours: 20:00
Bristol-Myers Squibb Market Cap: 97.63B for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 17, 2024 | 96.74B |
| April 16, 2024 | 97.59B |
| April 15, 2024 | 98.10B |
| April 12, 2024 | 97.63B |
| April 11, 2024 | 99.33B |
| April 10, 2024 | 101.70B |
| April 09, 2024 | 104.35B |
| April 08, 2024 | 103.33B |
| April 05, 2024 | 103.78B |
| April 04, 2024 | 103.94B |
| April 03, 2024 | 105.52B |
| April 02, 2024 | 106.65B |
| April 01, 2024 | 107.16B |
| March 28, 2024 | 109.66B |
| March 27, 2024 | 107.68B |
| March 26, 2024 | 106.27B |
| March 25, 2024 | 105.66B |
| March 22, 2024 | 105.01B |
| March 21, 2024 | 104.32B |
| March 20, 2024 | 104.91B |
| March 19, 2024 | 104.75B |
| March 18, 2024 | 104.32B |
| March 15, 2024 | 105.84B |
| March 14, 2024 | 106.14B |
| March 13, 2024 | 106.47B |
| Date | Value |
|---|---|
| March 12, 2024 | 110.01B |
| March 11, 2024 | 109.93B |
| March 08, 2024 | 108.77B |
| March 07, 2024 | 107.74B |
| March 06, 2024 | 107.94B |
| March 05, 2024 | 104.79B |
| March 04, 2024 | 102.97B |
| March 01, 2024 | 102.91B |
| February 29, 2024 | 102.63B |
| February 28, 2024 | 102.97B |
| February 27, 2024 | 102.14B |
| February 26, 2024 | 102.16B |
| February 23, 2024 | 104.47B |
| February 22, 2024 | 103.80B |
| February 21, 2024 | 102.95B |
| February 20, 2024 | 100.83B |
| February 16, 2024 | 100.83B |
| February 15, 2024 | 99.98B |
| February 14, 2024 | 98.87B |
| February 13, 2024 | 98.50B |
| February 12, 2024 | 100.60B |
| February 09, 2024 | 100.73B |
| February 08, 2024 | 98.50B |
| February 07, 2024 | 98.36B |
| February 06, 2024 | 99.61B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
69.96B
Minimum
Jul 22 2019
172.50B
Maximum
Dec 02 2022
131.34B
Average
137.97B
Median
Market Cap Benchmarks
| Amgen Inc | 140.79B |
| Gilead Sciences Inc | 82.40B |
| Johnson & Johnson | 351.01B |
| Karuna Therapeutics Inc (DELISTED) | -- |
| 2seventy bio Inc | 238.34M |
Market Cap Related Metrics
| PE Ratio | 12.51 |
| PS Ratio | 2.229 |
| PEG Ratio | 0.4055 |
| Price to Book Value | 3.317 |
| Price to Free Cash Flow | 7.930 |
| Price | 48.30 |
| Earnings Yield | 8.00% |
| PEGY Ratio | 0.3500 |
| Operating PE Ratio | 12.24 |
| Normalized PE Ratio | 12.74 |